Aziz-Ur Rehman
Finanzdirektor/CFO bei GOLDEN AGE EXPLORATION LTD.
Profil
Aziz-Ur Rehman is currently working as a Controller at KOP Therapeutics Corp.
since 2021 and as the Chief Financial Officer & Secretary at Golden Age Exploration Ltd.
since 2022.
Previously, he worked as the Chief Financial Officer & Director at AEL Textiles Ltd.
and as an Accountant at Hampsom Equities Ltd.
from 2016 to 2019.
Mr. Rehman completed his undergraduate degree at Athabasca University.
Aktive Positionen von Aziz-Ur Rehman
| Unternehmen | Position | Beginn |
|---|---|---|
| GOLDEN AGE EXPLORATION LTD. | Finanzdirektor/CFO | 11.01.2022 |
KOP Therapeutics Corp.
 KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | Comptroller/Controller/Auditor | 01.02.2021 |
Ehemalige bekannte Positionen von Aziz-Ur Rehman
| Unternehmen | Position | Ende |
|---|---|---|
| Hampsom Equities Ltd. | Comptroller/Controller/Auditor | 01.03.2019 |
| AEL TEXTILES LIMITED | Finanzdirektor/CFO | - |
Ausbildung von Aziz-Ur Rehman
| Athabasca University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GOLDEN AGE EXPLORATION LTD. | Non-Energy Minerals |
| Private Unternehmen | 3 |
|---|---|
AEL Textiles Ltd.
 AEL Textiles Ltd. Alternative Power GenerationUtilities AEL Textiles Ltd. engages in dealing and trading of textile products and materials. The company was founded on February 20, 1994 and is headquartered in Lahore, Pakistan. | Utilities |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | Health Technology |
| Hampsom Equities Ltd. |
